History
Company Milestone
| Time | Achievement |
|---|---|
| 2016 | Treatment of influenza published in journal of Scientific Report 2016 Apr 12;6:24253. |
| 2015 | Algapharma Biotech Corp. obtained Bronze Award of “2015 Taiwan Healthcare and Agricultural Biotech Industries and Excellence Award. |
| 2014 | • CV-66 application as immune adjustment health food is officially received by SFDA. • Apomivir® grants TW FDA IND approval for phase II clinical trials. |
| 2013 | LS-66® Major Function Approved and Certified By The Taiwan Department of Health (No. A00241). |
| 2012 | Bpogen® spirulina capsule receives innovative award from Health Food Society of Taiwan. |
| 2011 | • Scientific and Technological Agribusiness Awards by Council of Agriculture, Executive Yuan. • FEBICO is nominated for both Innovative Research category and Technology Application category. |
| 2010 | • FEBICO obtained CAITA Innovative Enterprise Award. • FEBICO obtained BioTaiwan Innovation and Excellence Award. • FEBICO obtained Ministry of Economic Affairs. • FEBICO obtained SME Innovative Award. |
| 2009 | FEBICO was nominated in the most honorable 2009 Taipei Biotech awards, and was awarded with Technology Commercialization Silver award. |
| 2008 | Apogen® received Taiwanese patent for a method for Inhibiting Enterovirus and/or Influenza Virus reproduction by Allophycocyanin in vitro. |
| 2007 | Apogen® prevents Influenza type A and type B virus infection and replication in a cocktail treatment. (R.O.C Patent I-272947) |
| 2006 | Obtained the SBIR program compensation from The Dept. of Industrial Technology (DoIT) of Ministry of Economic Affairs (MOEA) in Taiwan. |
| 2005 | • Oral dosage of Apogen can prevent viral infection. (R.O.C. patent I 240631) • National Quality Award for Certified Organic Spirulina and “Certificate of Symbol for National Quality”. Both awards recognize the continued excellence in the quality of FEBICO Premium Organic Spirulina. • Organic chlorella and Spirulina certified by Chinese Organic Agricertification Association. |
| 2004 | • Apogen® Children Granules received Nutraceutical Innovation Award approved by Health Food Society of Taiwan. • FEBICO signed contract to collaborate with HungKuang University |
| 2003 | • Publish research studies with Chang Gung University • Formal introduction of Apogen in the market • Research grant approved from Ministry of Economic Affairs, R.O.C. • Cracked Chlorella Cell Wall (R.O.C. Patent: 183428) |
| 2002 | • Organic Spirulina Certification (NL-RC-1309-B) • Apogen® is effective in preventing enterovirus 71 and influenza A, B infection (U.S. patent 6346408 ) • Received research grant from SBIR program from SMEA of Ministry of Economic Affairs in Taiwan. |
| 2001 | Initiated development of microalgae specialized protein in cancer diagnostics. |
| 2000 | Successfully develop phycobiliproteins for immunology research use. |
| 1998 | Initiated microalgae biomedical research. |
| 1995 | Initiation of microalgae phycobiliproteins development. |
| 1990 | Establishment of FEBICO microalgae lab. Joint collaboration with FEMICO to develop high valued microalgae product. |
| 1976 | FEMICO (Far East Microalgae Industries, Co., Ltd) was founnded in 1976. |
